Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases

Published:2024-04-02 Issue:4 Volume:53 Page:255-262
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Ayano M¹^ORCID,Tsubouchi K²^ORCID,Suzuki K²,Kimoto Y¹^ORCID,Arinobu Y¹^ORCID,Akashi K¹^ORCID,Horiuchi T³^ORCID,Okamoto I²^ORCID,Niiro H⁴^ORCID

Affiliation:

1. Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

2. Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

3. Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan

4. Department of Medical Education, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Funder

JSPS KAKENHI

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2024.2327159

Reference40 articles.

1. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

2. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations

3. Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease

4. Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review

5. Treatment of the Connective Tissue Disease–Related Interstitial Lung Diseases: A Narrative Review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3